Glucuronides in the gut: Sugar-driven symbioses between microbe and host

Journal of Biological Chemistry

Volumn 292, Issue 21, 2017, Pages 8569-8576

  Pellock, Samuel J ^a   Redinbo, Matthew R ^a  

^a University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON; GLUCOSE; MAMMALS; MICROORGANISMS; PLANTS (BOTANY); PROTEINS;

BETA-GLUCURONIDASE; COMPLEMENTARY SYSTEMS; INTESTINAL TRACT; MAMMALIAN SYSTEMS; MECHANISTIC STUDIES; MICROBIAL PROTEINS; MOLECULAR INSIGHTS; XENOBIOTIC COMPOUNDS;

BACTERIA;

ARACHIDONIC ACID; BELINOSTAT; BETA GLUCURONIDASE; BILIRUBIN; BILIRUBIN GLUCURONIDE; CHENODEOXYCHOLIC ACID; CHONDROITIN SULFATE; DICLOFENAC; DOPAMINE; ESTRADIOL; FIRTECAN; GLUCURONIDE; HYALURONIC ACID; INDOMETACIN; IRINOTECAN; KETOPROFEN; LAPATINIB; METHYLAZOXYMETHANOL; NORADRENALIN; PANOBINOSTAT; SEROTONIN; TESTOSTERONE; THYROXINE; BACTERIAL PROTEIN; XENOBIOTIC AGENT;

ARTICLE; BACTERIAL METABOLISM; ENZYME ACTIVITY; ENZYME REGULATION; GASTROINTESTINAL TOXICITY; HOMEOSTASIS; HUMAN; INTESTINE FLORA; LIPID BLOOD LEVEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYMBIOSIS; ANIMAL; INTESTINE; METABOLISM; MICROBIOLOGY; PHYSIOLOGY;

ANIMALS; BACTERIAL PROTEINS; GASTROINTESTINAL MICROBIOME; GLUCURONIDASE; GLUCURONIDES; HUMANS; INTESTINES; SYMBIOSIS; XENOBIOTICS;

EID: 85019765671     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.R116.767434     Document Type: Article

References (91)

1. Goldin, B. R. (1986) In situ bacterial metabolism and colon mutagens. Annu. Rev. Microbiol. 40, 367-393
2. Goldin, B. R., and Gorbach, S. L. (1976) The relationship between diet and rat fecal bacterial enzymes implicated in colon cancer. J. Natl. Cancer Inst. 57, 371-375
3. Lombardi, P., Goldin, B., Boutin, E., and Gorbach, S. L. (1978) Metabolism of androgens and estrogens by human fecal microorganisms. J. Steroid Biochem. 9, 795-801
4. Winter, J., and Bokkenheuser, V. D. (1987) Bacterial metabolism of natural and synthetic sex hormones undergoing enterohepatic circulation. J. Steroid Biochem. 27, 1145-1149
5. Asano, Y., Hiramoto, T., Nishino, R., Aiba, Y., Kimura, T., Yoshihara, K., Koga, Y., and Sudo, N. (2012) Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice. Am. J. Physiol. Gastrointest. Liver Physiol. 303, G1288-G1295
6. Kim, D. H., and Jin, Y. H. (2001) Intestinal bacterial β-glucuronidase activity of patients with colon cancer. Arch. Pharm. Res. 24, 564-567
7. Grosse, L., Pâquet, S., Caron, P., Fazli, L., Rennie, P. S., Bélanger, A., and Barbier, O. (2013) Androgen glucuronidation: an unexpected target for androgen deprivation therapy, with prognosis and diagnostic implications. Cancer Res. 73, 6963-6971
8. Plotnikoff, G. A. (2014) Three measurable and modifiable enteric microbial biotransformations relevant to cancer prevention and treatment. Glob. Adv. Health Med. 3, 33-43
9. Gloux, K., and Anba-Mondoloni, J. (2016) Unique β-glucuronidase locus in gut microbiomes of Crohn's disease patients and unaffected first-degree relatives. PLoS ONE 11, e0148291
10. Dutton, G. J. (ed) (1966) Glucuronic Acid, Free and Combined, Biochemistry, Pharmacology, and Medicine. Academic Press, Orlando, FL
11. Dutton, G. J. (ed) (1980) Glucuronidation of Drugs and Other Compounds, pp. 69-74, CRC Press, Inc., Boca Raton, FL
12. Peekhaus, N., and Conway, T. (1998) What's for dinner?: Entner-Doudoroff metabolism in Escherichia coli. J. Bacteriol. 180, 3495-3502
13. Jain, S., Drendel, W. B., Chen, Z. W., Mathews, F. S., Sly, W. S., and Grubb, J. H. (1996) Structure of human β-glucuronidase reveals candidate lysosomal targeting and active-site motifs. Nat. Struct. Biol. 3, 375-381
14. Sly, W. S., Quinton, B. A., McAlister, W. H., and Rimoin, D. L. (1973) β-Glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis. J. Pediatr. 82, 249-257
15. Sperker, B., Backman, J. T., and Kroemer, H. K. (1997) The role of β-glucuronidase in drug disposition and drug targeting in humans. Clin. Pharmacokinet. 33, 18-31
16. Wilson, K. J., Hughes, S. G., and Jefferson, R. (1992) in The Escherichia coli gus Operon: Induction and Expression of the gus Operon in E. coli and the Occurrence and Use of GUS in Other Bacteria (Gallagher, S. R., ed) pp. 7-22, Academic Press, Inc., San Diego
17. Roberts, M. S., Magnusson, B. M., Burczynski, F. J., and Weiss, M. (2002) Enterohepatic circulation: physiological, pharmacokinetic and clinical implications. Clin. Pharmacokinet. 41, 751-790
18. Vítek, L., and Carey, M. C. (2003) Enterohepatic cycling of bilirubin as a cause of "black" pigment gallstones in adult life. Eur. J. Clin. Invest. 33, 799-810
19. Fevery, J., Blanckaert, N., Leroy, P., Michiels, R., and Heirwegh, K. P. (1983) Analysis of bilirubins in biological fluids by extraction and thin-layer chromatography of the intact tetrapyrroles: application to bile of patients with Gilbert's syndrome, hemolysis, or cholelithiasis. Hepatology 3, 177-183
20. Vítek, L., Kotal, P., Jirsa, M., Malina, J., Cerná, M., Chmelar, D., and Fevery, J. (2000) Intestinal colonization leading to fecal urobilinoid excretion may play a role in the pathogenesis of neonatal jaundice. J. Pediatr. Gastroenterol. Nutr. 30, 294-298
21. Stocker, R., Yamamoto, Y., McDonagh, A. F., Glazer, A. N., and Ames, B. N. (1987) Bilirubin is an antioxidant of possible physiological importance. Science. 235, 1043-1046
22. Vítek, L., and Ostrow, J. D. (2009) Bilirubin chemistry and metabolism; harmful and protective aspects. Curr. Pharm. Des. 15, 2869-2883
23. Maki, T. (1966) Pathogenesis of calcium bilirubinate gallstone: role of E. coli, β-glucuronidase and coagulation by inorganic ions, polyelectrolytes and agitation. Ann. Surg. 164, 90-100
24. Shen, H., Ye, F., Xie, L., Yang, J., Li, Z., Xu, P., Meng, F., Li, L., Chen, Y., Bo, X., Ni, M., and Zhang, X. (2015) Metagenomic sequencing of bile from gallstone patients to identify different microbial community patterns and novel biliary bacteria. Sci. Rep. 5, 17450
25. Ye, F., Shen, H., Li, Z., Meng, F., Li, L., Yang, J., Chen, Y., Bo, X., Zhang, X., and Ni, M. (2016) Influence of the biliary system on biliary bacteria revealed by bacterial communities of the human biliary and upper digestive tracts. PLoS ONE 11, e0150519
26. Raftogianis, R., Creveling, C., Weinshilboum, R., and Weisz, J. (2000) Estrogen metabolism by conjugation. J. Natl. Cancer Inst. Monogr. 2000, 113-124
27. Graef, V., Furuya, E., and Nishikaze, O. (1977) Hydrolysis of steroid glucuronides with β-glucuronidase preparations from bovine liver, helix pomatia, and E. coli. Clin. Chem. 23, 532-535
28. Sher, A., and Rahman, M. A. (2000) Enterohepatic recycling of estrogen and its relevance with female fertility. Arch. Pharm. Res. 23, 513-517
29. Sandberg, A. A., Kirdani, R. Y., Back, N., Weyman, P., and Slaunwhite, W. R. (1967) Biliary excretion and enterohepatic circulation of estrone and estriol in rodents. Am. J. Physiol. 213, 1138-1142
30. Kwa, M., Plottel, C. S., Blaser, M. J., and Adams, S. (2016) The intestinal microbiome and estrogen receptor-positive female breast cancer. J. Natl. Cancer Inst. 108, 1-10
31. Ulmer, J. E., Vilén, E. M., Namburi, R. B., Benjdia, A., Beneteau, J., Malleron, A., Bonnaffé, D., Driguez, P. A., Descroix, K., Lassalle, G., Le Narvor, C., Sandström, C., Spillmann, D., and Berteau, O. (2014) Characterization of glycosaminoglycan (GAG) sulfatases from the human gut symbiont Bacteroides thetaiotaomicron reveals the first GAG-specific bacterial endosulfatase. J. Biol. Chem. 289, 24289-24303
32. Kreek, M. J., Guggenheim, F. G., Ross, J. E., and Tapley, D. F. (1963) Glucuronide formation in the transport of testosterone and androstenedione by rat intestine. Biochim. Biophys. Acta 74, 418-427
33. Yamanaka, H., Nakajima, M., Katoh, M., and Yokoi, T. (2007) Glucuronidation of thyroxine in human liver, jejunum, and kidney microsomes. Drug Metab. Dispos. 35, 1642-1648
34. Hazenberg, M. P., de Herder, W. W., and Visser, T. J. (1988) Hydrolysis of iodothyronine conjugates by intestinal bacteria. FEMS Microbiol. Rev. 4, 9-16
35. DiStefano, J. J., 3rd., de Luze, A., and Nguyen, T. T. (1993) Binding and degradation of 3,5,3 β-triiodothyronine and thyroxine by rat intestinal bacteria. Am. J. Physiol. 264, E966-E972
36. Zhang, J., and Lazar, M. (2000) The mechanism of action of thyroid hormones. Annu. Rev. Physiol. 62, 439-66
37. Eisenhofer, G., Aneman, A., Friberg, P., Hooper, D., Fandriks, L., Lonroth, H., Hunyady, B., and Mezey, E. (1997) Substantial production of dopamine in the human gastrointestinal tract. J. Clin. Endocrinol. Metab. 82, 3864-3871
38. Flemström, G., Säfsten, B., and Jedstedt, G. (1993) Stimulation of mucosal alkaline secretion in rat duodenum by dopamine and dopaminergic compounds. Gastroenterology. 104, 825-833
39. Haskel, Y., and Hanani, M. (1994) Inhibition of gastrointestinal motility by MPTP via adrenergic and dopaminergic mechanisms. Dig. Dis. Sci. 39, 2364-2367
40. Krishnaswamy, S., Duan, S. X., Von Moltke, L. L., Greenblatt, D. J., Sudmeier, J. L., Bachovchin, W. W., and Court, M. H. (2003) Serotonin (5-hydroxytryptamine) glucuronidation in vitro: assay development, human liver microsome activities and species differences. Xenobiotica 33, 169-180
41. Wikoff, W. R., Anfora, A. T., Liu, J., Schultz, P. G., Lesley, S. A., Peters, E. C., and Siuzdak, G. (2009) Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc. Natl. Acad. Sci. U.S.A. 106, 3698-3703
42. Hofmann, A. F. (2009) The enterohepatic circulation of bile acids in mammals: form and functions. Front. Biosci. 14, 2584-2598
43. Devlin, A. S., and Fischbach, M. A. (2015) A biosynthetic pathway for a prominent class of microbiota-derived bile acids. Nat. Chem. Biol. 11, 685-690
44. Matern, S., Matern, H., Farthmann, E. H., and Gerok, W. (1984) Hepatic and extrahepatic glucuronidation of bile acids in man. Characterization of bile acid uridine 5′-diphosphate-glucuronosyltransferase in hepatic, renal, and intestinal microsomes. J. Clin. Invest. 74, 402-410
45. Almé, B., and Sjövall, J. (1980) Analysis of bile acid glucuronides in urine. identification of 3α,6α,12α-trihydroxy-5β-cholanoic acid. J. Steroid Biochem. 13, 907-916
46. Kremmyda, L.-S., Tvrzicka, E., Stankova, B., and Zak, A. (2011) Fatty acids as biocompounds: their role in human metabolism, health and disease-a review. Part 2: fatty acid physiological roles and applications in human health and disease. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 155, 195-218
47. Prakash, C., Zhang, J. Y., Falck, J. R., Chauhan, K., and Blair, I. A. (1992) 20-Hydroxyeicosatetraenoic acid is excreted as a glucuronide conjugate in human urine. Biochem. Biophys. Res. Commun. 185, 728-733
48. Barua, A. B., and Olson, J. A. (1986) Retinoyl β-glucuronide: an endogenous compound of human blood. Am. J. Clin. Nutr. 43, 481-485
49. Little, J. M., Kurkela, M., Sonka, J., Jäntti, S., Ketola, R., Bratton, S., Finel, M., and Radominska-Pandya, A. (2004) Glucuronidation of oxidized fatty acids and prostaglandins B1 and E2 by human hepatic and recombinant UDP-glucuronosyltransferases. J. Lipid Res. 45, 1694-1703
50. Salyers, A. A., and O'Brien, M. (1980) Cellular location of enzymes involved in chondroitin sulfate breakdown by Bacteroides thetaiotaomicron. J. Bacteriol. 143, 772-780
51. Koropatkin, N. M., Cameron, E. A., and Martens, E. C. (2012) How glycan metabolism shapes the human gut microbiota. Nat. Rev. Microbiol. 10, 323-335
52. Pommier, Y. (2006) Topoisomerase I inhibitors: camptothecins and beyond. Nat. Rev. Cancer 6, 789-802
53. Cantore, M., Rabbi, C., Fiorentini, G., Oliani, C., Zamagni, D., Iacono, C., Mambrini, A., Del Freo, A., and Manni, A. (2004) Combined irinotecan and oxaliplatin in patients with advanced pre-treated pancreatic cancer. Oncology 67, 93-97
54. Robert, J., and Rivory, L. (1998) Pharmacology of irinotecan. Drugs Today 34, 777-803
55. Wallace, B. D., Wang, H., Lane, K. T., Scott, J. E., Orans, J., Koo, J. S., Venkatesh, M., Jobin, C., Yeh, L.-A., Mani, S., and Redinbo, M. R. (2010) Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 330, 831-835
56. Wallace, B. D., Roberts, A. B., Pollet, R. M., Ingle, J. D., Biernat, K. A., Pellock, S. J., Venkatesh, M. K., Guthrie, L., O'Neal, S. K., Robinson, S. J., Dollinger, M., Figueroa, E., McShane, S. R., Cohen, R. D., Jin, J., et al. (2015) Structure and inhibition of microbiome β-glucuronidases essential to the alleviation of cancer drug toxicity. Chem. Biol. 22, 1238-1249
57. Wang, L. Z., Ramírez, J., Yeo, W., Chan, M. Y., Thuya, W. L., Lau, J. Y., Wan, S. C., Wong, A. L., Zee, Y. K., Lim, R., Lee, S. C., Ho, P. C., Lee, H. S., Chan, A., Ansher, S., et al. (2013) Glucuronidation by UGT1A1 is the dominant pathway of the metabolic disposition of belinostat in liver cancer patients. PLoS ONE 8, e54522
58. Anne, M., Sammartino, D., Barginear, M. F., and Budman, D. (2013) Profile of panobinostat and its potential for treatment in solid tumors: an update. Onco. Targets. Ther. 6, 1613-1624
59. Castellino, S., O'Mara, M., Koch, K., Borts, D. J., Bowers, G. D., and MacLauchlin, C. (2012) Human metabolism of lapatinib, a dual kinase inhibitor: implications for hepatotoxicity. Drug Metab. Dispos. 40, 139-150
60. Regan, S. L., Maggs, J. L., Hammond, T. G., Lambert, C., and Williams, D. P., and Park, B. K. (2010) Acyl glucuronides: the good, the bad and the ugly. Biopharm. Drug Dispos. 31, 367-395
61. LoGuidice, A., Wallace, B. D., Bendel, L., Redinbo, M. R., and Boelsterli, U. A. (2012) Pharmacologic targeting of bacterial β-glucuronidase alleviates nonsteroidal anti-inflammatory drug-induced enteropathy in mice. J. Pharmacol. Exp. Ther. 341, 447-454
62. Saitta, K. S., Zhang, C., Lee, K. K., Fujimoto, K., Redinbo, M. R., and Boelsterli, U. A. (2014) Bacterial β-glucuronidase inhibition protects mice against enteropathy induced by indomethacin, ketoprofen or diclofenac: mode of action and pharmacokinetics. Xenobiotica 44, 28-35
63. Somasundaram, S., Rafi, S., Hayllar, J., Sigthorsson, G., Jacob, M., Price, A. B., Macpherson, A., Mahmod, T., Scott, D., Wrigglesworth, J. M., and Bjarnason, I. (1997) Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine. Gut 41, 344-353
64. Boelsterli, U. A., Redinbo, M. R., and Saitta, K. S. (2013) Multiple NSAIDinduced hits injure the small intestine: underlying mechanisms and novel strategies. Toxicol. Sci. 131, 654-667
65. Femia, A. P., and Caderni, G. (2008) Rodent models of colon carcinogenesis for the study of chemopreventive activity of natural products. Planta Med. 74, 1602-1607
66. Megaraj, V., Ding, X., Fang, C., Kovalchuk, N., Zhu, Y., and Zhang, Q. Y. (2014) Role of hepatic and intestinal P450 enzymes in the metabolic activation of the colon carcinogen azoxymethane in mice. Chem. Res. Toxicol. 27, 656-662
67. Laqueur, G. L., Matsumoto, H., and Yamamoto, R. S. (1981) Comparison of the carcinogenicity of methylazoxymethanol-β-D-glucosiduronic acid in conventional and germfree Sprague-Dawley rats. J. Natl. Cancer Inst. 67, 1053-1055
68. Takada, H., Hirooka, T., Hiramatsu, Y., and Yamamoto, M. (1982) Effect of β-glucuronidase inhibitor on azoxymethane-induced colonic carcinogenesis in rats. Cancer Res. 42, 331-334
69. Gu, D., McNaughton, L., Lemaster, D., Lake, B. G., Gooderham, N. J., Kadlubar, F. F., Turesky, R. J. (2010) A comprehensive approach to the profiling of cooked meat carcinogens 2-amino-3,8-dimethylimidazo[4,5- f]quinoxaline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, and their metabolites in human urine. Chem. Res. Toxicol. 23, 788-801
70. Zheng, Z., Fang, J. L., and Lazarus, P. (2002) Glucuronidation: an important mechanism for detoxification of benzo[a]pyrene metabolites in aerodigestive tract tissues. Drug Metab. Dispos. 30, 397-403
71. Schmitt, G., Aderjan, R., Keller, T., and Wu, M. (1995) Ethyl glucuronide: an unusual ethanol metabolite in humans. Synthesis, analytical data, and determination in serum and urine. J. Anal. Toxicol. 19, 91-94
72. Palmer, R. B. (2009) A review of the use of ethyl glucuronide as a marker for ethanol consumption in forensic and clinical medicine. Semin. Diagn. Pathol. 26, 18-27
73. Baranowski, S., Serr, A., Thierauf, A., Weinmann, W., Grosse Perdekamp, M., Wurst, F. M., and Halter, C. C. (2008) In vitro study of bacterial degradation of ethyl glucuronide and ethyl sulphate. Int. J. Legal Med. 122, 389-393
74. Morini, L., Politi, L., Groppi, A., Stramesi, C., and Polettini, A. (2006) Determination of ethyl glucuronide in hair samples by liquid chromatography/ electrospray tandem mass spectrometry. J. Mass Spectrom. 41, 34-42
75. Chen, G., Giambrone, N. E., Jr., Dluzen, D. F., Muscat, J. E., Berg, A., Gallagher, C. J., and Lazarus, P. (2010) Glucuronidation genotypes and nicotine metabolic phenotypes: importance of functional UGT2B10 and UGT2B17 polymorphisms. Cancer Res. 70, 7543-7552
76. Byrd, G. D., Chang, K. M., Greene, J. M., and deBethizy, J. D. (1992) Evidence for urinary excretion of glucuronide conjugates of nicotine, cotinine, and trans-3′-hydroxycotinine in smokers. Drug Metab. Dispos. 20, 192-197
77. Montenegro M. A., Boiero, M. L., Valle, L., and Borsarelli, C. D. (2012) Gum Arabic: more than an edible emulsifier. Products and Applications of Biopolymers. InTech. 10.5772/33783
78. Babiker, R., Merghani, T. H., Elmusharaf, K., Badi, R. M., Lang, F., and Saeed, A. M. (2012) Effects of Gum Arabic ingestion on body mass index and body fat percentage in healthy adult females: two-arm randomized, placebo controlled, double-blind trial. Nutr. J. 11, 111
79. Chakdar, H., Kumar, M., Pandiyan, K., Singh, A., Nanjappan, K., Kashyap, P. L., and Srivastava, A. K. (2016) Bacterial xylanases: biology to biotechnology. 3 Biotech. 6, 150
80. Goldin, B. R., and Gorbach, S. L. (1984) The effect of milk and Lactobacillus feeding on human intestinal bacterial enzyme activity. Am. J. Clin. Nutr. 39, 756-761
81. Beaud, D., Tailliez, P., and Anba-Mondoloni, J. (2005) Genetic characterization of the β-glucuronidase enzyme from a human intestinal bacterium, Ruminococcus gnavus. Microbiology 151, 2323-2330
82. Dabek, M., McCrae, S. I., Stevens, V. J., Duncan, S. H., and Louis, P. (2008) Distribution of β-glucosidase and β-glucuronidase activity and of β-glucuronidase gene gus in human colonic bacteria. FEMS Microbiol. Ecol. 66, 487-495
83. Gadelle, D., Raibaud, P., and Sacquet, E. (1985) β-Glucuronidase activities of intestinal bacteria determined both in vitro and in vivo in gnotobiotic rats. Appl. Environ. Microbiol. 49, 682-685
84. Gloux, K., Berteau, O., El Oumami, H., Béguet, F., Leclerc, M., and Doré, J. (2011) A metagenomic β-glucuronidase uncovers a core adaptive function of the human intestinal microbiome. Proc. Natl. Acad. Sci. U.S.A. 108, 4539-4546
85. Kim, D. H., Hong, S. W., Kim, B. T., Bae, E. A., Park, H. Y., and Han, M. J. (2000) Biotransformation of glycyrrhizin by human intestinal bacteria and its relation to biological activities. Arch. Pharm. Res. 23, 172-177
86. McBain, A. J., and Macfarlane, G. T. (1998) Ecological and physiological studies on large intestinal bacteria in relation to production of hydrolytic and reductive enzymes involved in formation of genotoxic metabolites. J. Med. Microbiol. 47, 407-416
87. Nakamura, J., Kubota, Y., Miyaoka, M., Saitoh, T., Mizuno, F., and Benno, Y. (2002) Comparison of four microbial enzymes in Clostridia and Bacteroides isolated from human feces. Microbiol. Immunol. 46, 487-490
88. Russell, W. M., and Klaenhammer, T. R. (2001) Identification and cloning of gusA, encoding a new β-glucuronidase from Lactobacillus gasseri ADH. Appl. Environ. Microbiol. 67, 1253-1261
89. Trottier, J., Verreault, M., Grepper, S., Monté, D., Bélanger, J., Kaeding, J., Caron, P., Inaba, T. T., and Barbier, O. (2006) Human UDP-glucuronosyltransferase (UGT)1A3 enzyme conjugates chenodeoxycholic acid in the liver. Hepatology 44, 1158-1170
90. Theocharis, A. D. (2002) Human colon adenocarcinoma is associated with specific post-translational modifications of versican and decorin. Biochim. Biophys. Acta 1588, 165-172
91. Halter, C. C., Dresen, S., Auwaerter, V., Wurst, F. M., and Weinmann, W. (2008) Kinetics in serum and urinary excretion of ethyl sulfate and ethyl glucuronide after medium dose ethanol intake. Int. J. Legal Med. 122, 123-128